Vaitaitis, G. M., Olmstead, M. H., Waid, D. M., Carter, J. R., & Wagner, D. H. (2019). CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter]. Diabetologia.

Vaitaitis, Gisela M., Michael H. Olmstead, Dan M. Waid, Jessica R. Carter, and David H. Wagner. "CD40-targeted Peptide Proposed for Type 1 Diabetes Therapy Lacks Relevant Binding Affinity to Its Cognate Receptor. Reply to Pagni PP, Wolf A, Lo Conte M Et Al [letter]." Diabetologia 2019.

Vaitaitis, Gisela M., et al. "CD40-targeted Peptide Proposed for Type 1 Diabetes Therapy Lacks Relevant Binding Affinity to Its Cognate Receptor. Reply to Pagni PP, Wolf A, Lo Conte M Et Al [letter]." Diabetologia 2019.